Ambrx Biopharma was a clinical-stage biopharmaceutical company that developed antibody-drug conjugates and other targeted therapeutics using its proprietary expanded genetic code…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Ambrx Biopharma →Already a subscriber? Sign in
Xcout Intel tracks Ambrx Biopharma continuously — this profile deepens as new filings, funding, people and hiring data arrive.